IMUX
Price
$0.98
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
93.84M
Earnings call today
ORIC
Price
$9.88
Change
-$0.11 (-1.10%)
Updated
Aug 6 closing price
Capitalization
841.96M
Earnings call today
Interact to see
Advertisement

IMUX vs ORIC

Header iconIMUX vs ORIC Comparison
Open Charts IMUX vs ORICBanner chart's image
Immunic
Price$0.98
Change-$0.00 (-0.00%)
Volume$708.38K
Capitalization93.84M
Oric Pharmaceuticals
Price$9.88
Change-$0.11 (-1.10%)
Volume$853.19K
Capitalization841.96M
IMUX vs ORIC Comparison Chart in %
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. ORIC commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and ORIC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (IMUX: $0.98 vs. ORIC: $9.88)
Brand notoriety: IMUX and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 42% vs. ORIC: 63%
Market capitalization -- IMUX: $93.84M vs. ORIC: $841.96M
IMUX [@Biotechnology] is valued at $93.84M. ORIC’s [@Biotechnology] market capitalization is $841.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMUX and ORIC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 5 TA indicator(s) are bullish while ORIC’s TA Score has 5 bullish TA indicator(s).

  • IMUX’s TA Score: 5 bullish, 5 bearish.
  • ORIC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ORIC is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а +1.86% price change this week, while ORIC (@Biotechnology) price change was -7.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

IMUX is expected to report earnings on Aug 07, 2025.

ORIC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($842M) has a higher market cap than IMUX($93.8M). ORIC YTD gains are higher at: 22.429 vs. IMUX (-2.060). IMUX has higher annual earnings (EBITDA): -100.85M vs. ORIC (-145.48M). ORIC has more cash in the bank: 204M vs. IMUX (14.3M). IMUX has less debt than ORIC: IMUX (975K) vs ORIC (3.21M). IMUX (0) and ORIC (0) have equivalent revenues.
IMUXORICIMUX / ORIC
Capitalization93.8M842M11%
EBITDA-100.85M-145.48M69%
Gain YTD-2.06022.429-9%
P/E RatioN/AN/A-
Revenue00-
Total Cash14.3M204M7%
Total Debt975K3.21M30%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXORIC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBCY934.9914.99
+1.63%
Central Bancompany
RNLSY7.190.02
+0.28%
Renault SA
TTBKF12.52N/A
N/A
2020 BULKERS LTD.
BTRMF0.07N/A
N/A
Battery Mineral Resources Corp.
RGBPP0.06-0.01
-14.29%
Regen Biopharma, Inc.

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-1.10%
ERAS - ORIC
48%
Loosely correlated
-4.67%
KYMR - ORIC
46%
Loosely correlated
-3.77%
ROIV - ORIC
46%
Loosely correlated
+0.17%
ETNB - ORIC
46%
Loosely correlated
-2.17%
ARCT - ORIC
45%
Loosely correlated
+3.21%
More